Z-1046-2017 Class II Terminated
FDA device recall Z-1046-2017 was initiated by Merge Healthcare, Inc. on Mar 28, 2016 and is designated Class II. Reason for recall: If a reader selects Multi-study review prior to the original study completing its loading process and then immediately returns to image review of the original study, it is possible that not all… The recall status is terminated (terminated Apr 8, 2019). Affected quantity: 188 sites potentially have the effected versions.
Recall details
- Product Type
- Devices
- Report Date
- Jan 25, 2017
- Initiation Date
- Mar 28, 2016
- Termination Date
- Apr 8, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 188 sites potentially have the effected versions
Product description
Merge Cardio software. Product Usage: Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images, Hemodynamic studies and reports, measurements (via import from DICOM Structured Reporting, text files or optical character recognition of measurements captured on images) and cardiology signal (waveform) data.
Reason for recall
If a reader selects Multi-study review prior to the original study completing its loading process and then immediately returns to image review of the original study, it is possible that not all current images will be present for review, which could result in incorrect treatment/diagnosis.
Distribution pattern
US Nationwide Distribution
Code information
Versions: 9.0, 9.0.1, 9.0.2, 9.0.3, 9.0.4, 9.0.5, 9.0.6, 9.0.7, 9.0.8, 9.0.9, 10.0, 10.0.1, 10.1, 10.1.1, and 10.1.2
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1046-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026